Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 13 to 24 of 46 entries
Sorted by: Best Match Show Resources per page
Dynamic Stress Factor (DySF): A Significant Predictor of Severe Hypoglycemic Events in Children with Type 1 Diabetes.

Journal of diabetes & metabolism

Rawlings R, Yuan L, Shi H, Brehm W, Pop-Busui R, Nelson P.
PMID: 24349871
J Diabetes Metab. 2012 Feb 28;3:177. doi: 10.4172/2155-6156.1000177.

Hemoglobin A1c (HbA1c) is the current standard used in the clinical treatment of patients with diabetes. However, it has been shown that patients with similar HbA1c values may have widely different fluctuations in blood glucose values over the same...

Cite
Rawlings R, Yuan L, Shi H, et al. Dynamic Stress Factor (DySF): A Significant Predictor of Severe Hypoglycemic Events in Children with Type 1 Diabetes. J Diabetes Metab. 2012;3:177doi: 10.4172/2155-6156.1000177.
Rawlings, R., Yuan, L., Shi, H., Brehm, W., Pop-Busui, R., & Nelson, P. (2012). Dynamic Stress Factor (DySF): A Significant Predictor of Severe Hypoglycemic Events in Children with Type 1 Diabetes. Journal of diabetes & metabolism, 3177. https://doi.org/10.4172/2155-6156.1000177
Rawlings, Ra, et al. "Dynamic Stress Factor (DySF): A Significant Predictor of Severe Hypoglycemic Events in Children with Type 1 Diabetes." Journal of diabetes & metabolism vol. 3 (2012): 177. doi: https://doi.org/10.4172/2155-6156.1000177
Rawlings R, Yuan L, Shi H, Brehm W, Pop-Busui R, Nelson P. Dynamic Stress Factor (DySF): A Significant Predictor of Severe Hypoglycemic Events in Children with Type 1 Diabetes. J Diabetes Metab. 2012 Feb 28;3:177. doi: 10.4172/2155-6156.1000177. PMID: 24349871; PMCID: PMC3859451.
Copy Download .nbib Format: NLM
Associations of Microvascular Complications With the Risk of Cardiovascular Disease in Type 1 Diabetes.

Diabetes care

Gubitosi-Klug R, Gao X, Pop-Busui R, de Boer IH, White N, Aiello LP, Miller R, Palmer J, Tamborlane W, Wallia A, Kosiborod M, Lachin JM, Bebu I.
PMID: 33980605
Diabetes Care. 2021 Jul;44(7):1499-1505. doi: 10.2337/dc20-3104. Epub 2021 May 12.

OBJECTIVE: We examined whether the presence of microvascular complications was associated with increased subsequent risk of cardiovascular disease (CVD) among participants with type 1 diabetes in the Diabetes Control and Complications Trial and Epidemiology of Diabetes Interventions and Complications...

Cite
Gubitosi-Klug R, Gao X, Pop-Busui R, et al. Associations of Microvascular Complications With the Risk of Cardiovascular Disease in Type 1 Diabetes. Diabetes Care. 2021;44(7):1499-1505doi: 10.2337/dc20-3104.
Gubitosi-Klug, R., Gao, X., Pop-Busui, R., de Boer, I. H., White, N., Aiello, L. P., Miller, R., Palmer, J., Tamborlane, W., Wallia, A., Kosiborod, M., Lachin, J. M., Bebu, I. (2021). Associations of Microvascular Complications With the Risk of Cardiovascular Disease in Type 1 Diabetes. Diabetes care, 44(7), 1499-1505. https://doi.org/10.2337/dc20-3104
Gubitosi-Klug, Rose, et al. "Associations of Microvascular Complications With the Risk of Cardiovascular Disease in Type 1 Diabetes." Diabetes care vol. 44,7 (2021): 1499-1505. doi: https://doi.org/10.2337/dc20-3104
Gubitosi-Klug R, Gao X, Pop-Busui R, de Boer IH, White N, Aiello LP, Miller R, Palmer J, Tamborlane W, Wallia A, Kosiborod M, Lachin JM, Bebu I. Associations of Microvascular Complications With the Risk of Cardiovascular Disease in Type 1 Diabetes. Diabetes Care. 2021 Jul;44(7):1499-1505. doi: 10.2337/dc20-3104. Epub 2021 May 12. PMID: 33980605; PMCID: PMC8323173.
Copy Download .nbib Format: NLM
Angiotensin-Converting Enzyme Inhibitors, Angiotensin II Receptor Blockers, and Outcomes in Patients Hospitalized for COVID-19.

Journal of the American Heart Association

Pan M, Vasbinder A, Anderson E, Catalan T, Shadid HR, Berlin H, Padalia K, O'Hayer P, Meloche C, Azam TU, Khaleel I, Michaud E, Blakely P, Bitar A, Huang Y, Zhao L, Pop-Busui R, Loosen SH, Chalkias A, Tacke F, Giamarellos-Bourboulis EJ, Reiser J, Eugen-Olsen J, Hayek SS.
PMID: 34889102
J Am Heart Assoc. 2021 Dec 21;10(24):e023535. doi: 10.1161/JAHA.121.023535. Epub 2021 Dec 10.

Background Use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers (ACEi/ARB) is thought to affect COVID-19 through modulating levels of angiotensin-converting enzyme 2, the cell entry receptor for SARS-CoV2. We sought to assess the association between ACEi/ARB, biomarkers of...

Cite
Pan M, Vasbinder A, Anderson E, et al. Angiotensin-Converting Enzyme Inhibitors, Angiotensin II Receptor Blockers, and Outcomes in Patients Hospitalized for COVID-19. J Am Heart Assoc. 2021;10(24):e023535doi: 10.1161/JAHA.121.023535.
Pan, M., Vasbinder, A., Anderson, E., Catalan, T., Shadid, H. R., Berlin, H., Padalia, K., O'Hayer, P., Meloche, C., Azam, T. U., Khaleel, I., Michaud, E., Blakely, P., Bitar, A., Huang, Y., Zhao, L., Pop-Busui, R., Loosen, S. H., Chalkias, A., Tacke, F., Giamarellos-Bourboulis, E. J., Reiser, J., Eugen-Olsen, J., Hayek, S. S. (2021). Angiotensin-Converting Enzyme Inhibitors, Angiotensin II Receptor Blockers, and Outcomes in Patients Hospitalized for COVID-19. Journal of the American Heart Association, 10(24), e023535. https://doi.org/10.1161/JAHA.121.023535
Pan, Michael, et al. "Angiotensin-Converting Enzyme Inhibitors, Angiotensin II Receptor Blockers, and Outcomes in Patients Hospitalized for COVID-19." Journal of the American Heart Association vol. 10,24 (2021): e023535. doi: https://doi.org/10.1161/JAHA.121.023535
Pan M, Vasbinder A, Anderson E, Catalan T, Shadid HR, Berlin H, Padalia K, O'Hayer P, Meloche C, Azam TU, Khaleel I, Michaud E, Blakely P, Bitar A, Huang Y, Zhao L, Pop-Busui R, Loosen SH, Chalkias A, Tacke F, Giamarellos-Bourboulis EJ, Reiser J, Eugen-Olsen J, Hayek SS. Angiotensin-Converting Enzyme Inhibitors, Angiotensin II Receptor Blockers, and Outcomes in Patients Hospitalized for COVID-19. J Am Heart Assoc. 2021 Dec 21;10(24):e023535. doi: 10.1161/JAHA.121.023535. Epub 2021 Dec 10. PMID: 34889102.
Copy Download .nbib Format: NLM
Prevalence of microvascular and macrovascular disease in the Glycemia Reduction Approaches in Diabetes - A Comparative Effectiveness (GRADE) Study cohort.

Diabetes research and clinical practice

Mather KJ, Bebu I, Baker C, Cohen RM, Crandall JP, DeSouza C, Green JB, Kirkman MS, Krause-Steinrauf H, Larkin M, Pettus J, Seaquist ER, Soliman EZ, Schroeder EB, Wexler DJ, Pop-Busui R.
PMID: 32450102
Diabetes Res Clin Pract. 2020 Jul;165:108235. doi: 10.1016/j.diabres.2020.108235. Epub 2020 May 23.

AIMS: The Glycemia Reduction Approaches in Diabetes - A Comparative Effectiveness (GRADE) trial is a randomized clinical trial comparing glycemic effects of four diabetes medications added to metformin in type 2 diabetes (T2D). Microvascular and macrovascular diseases are secondary...

Cite
Mather KJ, Bebu I, Baker C, et al. Prevalence of microvascular and macrovascular disease in the Glycemia Reduction Approaches in Diabetes - A Comparative Effectiveness (GRADE) Study cohort. Diabetes Res Clin Pract. 2020;165:108235doi: 10.1016/j.diabres.2020.108235.
Mather, K. J., Bebu, I., Baker, C., Cohen, R. M., Crandall, J. P., DeSouza, C., Green, J. B., Kirkman, M. S., Krause-Steinrauf, H., Larkin, M., Pettus, J., Seaquist, E. R., Soliman, E. Z., Schroeder, E. B., Wexler, D. J., Pop-Busui, R. (2020). Prevalence of microvascular and macrovascular disease in the Glycemia Reduction Approaches in Diabetes - A Comparative Effectiveness (GRADE) Study cohort. Diabetes research and clinical practice, 165108235. https://doi.org/10.1016/j.diabres.2020.108235
Mather, Kieren J, et al. "Prevalence of microvascular and macrovascular disease in the Glycemia Reduction Approaches in Diabetes - A Comparative Effectiveness (GRADE) Study cohort." Diabetes research and clinical practice vol. 165 (2020): 108235. doi: https://doi.org/10.1016/j.diabres.2020.108235
Mather KJ, Bebu I, Baker C, Cohen RM, Crandall JP, DeSouza C, Green JB, Kirkman MS, Krause-Steinrauf H, Larkin M, Pettus J, Seaquist ER, Soliman EZ, Schroeder EB, Wexler DJ, Pop-Busui R. Prevalence of microvascular and macrovascular disease in the Glycemia Reduction Approaches in Diabetes - A Comparative Effectiveness (GRADE) Study cohort. Diabetes Res Clin Pract. 2020 Jul;165:108235. doi: 10.1016/j.diabres.2020.108235. Epub 2020 May 23. PMID: 32450102; PMCID: PMC7416515.
Copy Download .nbib Format: NLM
Incorporating SGLT2i and GLP-1RA for Cardiovascular and Kidney Disease Risk Reduction: Call for Action to the Cardiology Community.

Circulation

Nelson AJ, Pagidipati NJ, Aroda VR, Cavender MA, Green JB, Lopes RD, Al-Khalidi H, Gaynor T, Kaltenbach LA, Kirk JK, Lingvay I, Magwire ML, O'Brien EC, Pak J, Pop-Busui R, Richardson CR, Reed M, Senyucel C, Webb L, McGuire DK, Granger CB.
PMID: 34228476
Circulation. 2021 Jul 06;144(1):74-84. doi: 10.1161/CIRCULATIONAHA.121.053766. Epub 2021 Jul 06.

Multiple sodium glucose cotransporter-2 inhibitors (SGLT-2i) and glucagon-like peptide-1 receptor agonists (GLP-1RA) have been shown to impart significant cardiovascular and kidney benefits, but are underused in clinical practice. Both SGLT-2i and GLP-1RA were first studied as glucose-lowering drugs, which...

Cite
Nelson AJ, Pagidipati NJ, Aroda VR, et al. Incorporating SGLT2i and GLP-1RA for Cardiovascular and Kidney Disease Risk Reduction: Call for Action to the Cardiology Community. Circulation. 2021;144(1):74-84doi: 10.1161/CIRCULATIONAHA.121.053766.
Nelson, A. J., Pagidipati, N. J., Aroda, V. R., Cavender, M. A., Green, J. B., Lopes, R. D., Al-Khalidi, H., Gaynor, T., Kaltenbach, L. A., Kirk, J. K., Lingvay, I., Magwire, M. L., O'Brien, E. C., Pak, J., Pop-Busui, R., Richardson, C. R., Reed, M., Senyucel, C., Webb, L., McGuire, D. K., & Granger, C. B. (2021). Incorporating SGLT2i and GLP-1RA for Cardiovascular and Kidney Disease Risk Reduction: Call for Action to the Cardiology Community. Circulation, 144(1), 74-84. https://doi.org/10.1161/CIRCULATIONAHA.121.053766
Nelson, Adam J, et al. "Incorporating SGLT2i and GLP-1RA for Cardiovascular and Kidney Disease Risk Reduction: Call for Action to the Cardiology Community." Circulation vol. 144,1 (2021): 74-84. doi: https://doi.org/10.1161/CIRCULATIONAHA.121.053766
Nelson AJ, Pagidipati NJ, Aroda VR, Cavender MA, Green JB, Lopes RD, Al-Khalidi H, Gaynor T, Kaltenbach LA, Kirk JK, Lingvay I, Magwire ML, O'Brien EC, Pak J, Pop-Busui R, Richardson CR, Reed M, Senyucel C, Webb L, McGuire DK, Granger CB. Incorporating SGLT2i and GLP-1RA for Cardiovascular and Kidney Disease Risk Reduction: Call for Action to the Cardiology Community. Circulation. 2021 Jul 06;144(1):74-84. doi: 10.1161/CIRCULATIONAHA.121.053766. Epub 2021 Jul 06. PMID: 34228476.
Copy Download .nbib Format: NLM
Differences in Complications, Cardiovascular Risk Factor, and Diabetes Management among participants enrolled at Veterans Affairs (VA) and Non-VA Medical Centers in the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE).

Diabetes research and clinical practice

Florez HJ, Ghosh A, Pop-Busui R, Hox SH, Underkofler C, Diane McKee M, Park J, Rhee MK, Killean T, Krause-Steinrauf H, Aroda VR, Wexler DJ.
PMID: 34971663
Diabetes Res Clin Pract. 2021 Dec 28;109188. doi: 10.1016/j.diabres.2021.109188. Epub 2021 Dec 28.

AIMS: We evaluated differences in participants with type 2 diabetes (T2DM) enrolled in the GRADE study at VA vs non-VA sites, focusing on cardiovascular risk factors and rates of diabetes care target achievements.METHODS: We compared baseline characteristics between participants...

Cite
Florez HJ, Ghosh A, Pop-Busui R, et al. Differences in Complications, Cardiovascular Risk Factor, and Diabetes Management among participants enrolled at Veterans Affairs (VA) and Non-VA Medical Centers in the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE). Diabetes Res Clin Pract. 2021;109188doi: 10.1016/j.diabres.2021.109188.
Florez, H. J., Ghosh, A., Pop-Busui, R., Hox, S. H., Underkofler, C., Diane McKee, M., Park, J., Rhee, M. K., Killean, T., Krause-Steinrauf, H., Aroda, V. R., Wexler, D. J. (2021). Differences in Complications, Cardiovascular Risk Factor, and Diabetes Management among participants enrolled at Veterans Affairs (VA) and Non-VA Medical Centers in the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE). Diabetes research and clinical practice, 109188. https://doi.org/10.1016/j.diabres.2021.109188
Florez, Hermes J, et al. "Differences in Complications, Cardiovascular Risk Factor, and Diabetes Management among participants enrolled at Veterans Affairs (VA) and Non-VA Medical Centers in the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE)." Diabetes research and clinical practice vol. (2021): 109188. doi: https://doi.org/10.1016/j.diabres.2021.109188
Florez HJ, Ghosh A, Pop-Busui R, Hox SH, Underkofler C, Diane McKee M, Park J, Rhee MK, Killean T, Krause-Steinrauf H, Aroda VR, Wexler DJ. Differences in Complications, Cardiovascular Risk Factor, and Diabetes Management among participants enrolled at Veterans Affairs (VA) and Non-VA Medical Centers in the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE). Diabetes Res Clin Pract. 2021 Dec 28;109188. doi: 10.1016/j.diabres.2021.109188. Epub 2021 Dec 28. PMID: 34971663.
Copy Download .nbib Format: NLM
Beliefs Around Hypoglycemia and Their Impacts on Hypoglycemia Outcomes in Individuals with Type 1 Diabetes and High Risks for Hypoglycemia Despite Using Advanced Diabetes Technologies.

Diabetes care

Lin YK, Richardson CR, Dobrin I, DeJonckheere MJ, Mizokami-Stout K, Fetters MD, Aikens JE, Fisher SJ, Ye W, Pop-Busui R.
PMID: 35015079
Diabetes Care. 2022 Jan 10; doi: 10.2337/dc21-1285. Epub 2022 Jan 10.

OBJECTIVE: This study aimed to 1) identify the frequency of severe and level 2 hypoglycemia presenting in individuals with type 1 diabetes using continuous glucose monitoring systems (CGMs), including those with concomitant closed-loop insulin pumps, in a clinical practice...

Cite
Lin YK, Richardson CR, Dobrin I, et al. Beliefs Around Hypoglycemia and Their Impacts on Hypoglycemia Outcomes in Individuals with Type 1 Diabetes and High Risks for Hypoglycemia Despite Using Advanced Diabetes Technologies. Diabetes Care. 2022;doi: 10.2337/dc21-1285.
Lin, Y. K., Richardson, C. R., Dobrin, I., DeJonckheere, M. J., Mizokami-Stout, K., Fetters, M. D., Aikens, J. E., Fisher, S. J., Ye, W., & Pop-Busui, R. (2022). Beliefs Around Hypoglycemia and Their Impacts on Hypoglycemia Outcomes in Individuals with Type 1 Diabetes and High Risks for Hypoglycemia Despite Using Advanced Diabetes Technologies. Diabetes care, . https://doi.org/10.2337/dc21-1285
Lin, Yu Kuei, et al. "Beliefs Around Hypoglycemia and Their Impacts on Hypoglycemia Outcomes in Individuals with Type 1 Diabetes and High Risks for Hypoglycemia Despite Using Advanced Diabetes Technologies." Diabetes care vol. (2022). doi: https://doi.org/10.2337/dc21-1285
Lin YK, Richardson CR, Dobrin I, DeJonckheere MJ, Mizokami-Stout K, Fetters MD, Aikens JE, Fisher SJ, Ye W, Pop-Busui R. Beliefs Around Hypoglycemia and Their Impacts on Hypoglycemia Outcomes in Individuals with Type 1 Diabetes and High Risks for Hypoglycemia Despite Using Advanced Diabetes Technologies. Diabetes Care. 2022 Jan 10; doi: 10.2337/dc21-1285. Epub 2022 Jan 10. PMID: 35015079.
Copy Download .nbib Format: NLM
Risk of Foot Ulcer and Lower-Extremity Amputation Among Participants in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study.

Diabetes care

Boyko EJ, Zelnick LR, Braffett BH, Pop-Busui R, Cowie CC, Lorenzi GM, Gubitosi-Klug R, Zinman B, de Boer IH.
PMID: 35007329
Diabetes Care. 2022 Jan 06; doi: 10.2337/dc21-1816. Epub 2022 Jan 06.

OBJECTIVE: Intensive glycemic control reduces the risk of kidney, retinal, and neurologic complications in type 1 diabetes (T1D), but whether it reduces the risk of lower-extremity complications is unknown. We examined whether former intensive versus conventional glycemic control among...

Cite
Boyko EJ, Zelnick LR, Braffett BH, et al. Risk of Foot Ulcer and Lower-Extremity Amputation Among Participants in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study. Diabetes Care. 2022;doi: 10.2337/dc21-1816.
Boyko, E. J., Zelnick, L. R., Braffett, B. H., Pop-Busui, R., Cowie, C. C., Lorenzi, G. M., Gubitosi-Klug, R., Zinman, B., & de Boer, I. H. (2022). Risk of Foot Ulcer and Lower-Extremity Amputation Among Participants in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study. Diabetes care, . https://doi.org/10.2337/dc21-1816
Boyko, Edward J, et al. "Risk of Foot Ulcer and Lower-Extremity Amputation Among Participants in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study." Diabetes care vol. (2022). doi: https://doi.org/10.2337/dc21-1816
Boyko EJ, Zelnick LR, Braffett BH, Pop-Busui R, Cowie CC, Lorenzi GM, Gubitosi-Klug R, Zinman B, de Boer IH. Risk of Foot Ulcer and Lower-Extremity Amputation Among Participants in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study. Diabetes Care. 2022 Jan 06; doi: 10.2337/dc21-1816. Epub 2022 Jan 06. PMID: 35007329.
Copy Download .nbib Format: NLM
Diabetic Neuropathy: A Position Statement by the American Diabetes Association.

Diabetes care

Pop-Busui R, Boulton AJ, Feldman EL, Bril V, Freeman R, Malik RA, Sosenko JM, Ziegler D.
PMID: 27999003
Diabetes Care. 2017 Jan;40(1):136-154. doi: 10.2337/dc16-2042.

No abstract available.

Cite
Pop-Busui R, Boulton AJ, Feldman EL, et al. Diabetic Neuropathy: A Position Statement by the American Diabetes Association. Diabetes Care. 2017;40(1):136-154doi: 10.2337/dc16-2042.
Pop-Busui, R., Boulton, A. J., Feldman, E. L., Bril, V., Freeman, R., Malik, R. A., Sosenko, J. M., & Ziegler, D. (2017). Diabetic Neuropathy: A Position Statement by the American Diabetes Association. Diabetes care, 40(1), 136-154. https://doi.org/10.2337/dc16-2042
Pop-Busui, Rodica, et al. "Diabetic Neuropathy: A Position Statement by the American Diabetes Association." Diabetes care vol. 40,1 (2017): 136-154. doi: https://doi.org/10.2337/dc16-2042
Pop-Busui R, Boulton AJ, Feldman EL, Bril V, Freeman R, Malik RA, Sosenko JM, Ziegler D. Diabetic Neuropathy: A Position Statement by the American Diabetes Association. Diabetes Care. 2017 Jan;40(1):136-154. doi: 10.2337/dc16-2042. PMID: 27999003; PMCID: PMC6977405.
Copy Download .nbib Format: NLM
Longitudinal patterns of urinary incontinence and associated predictors in women with type 1 diabetes.

Neurourology and urodynamics

Bakre S, Holt SK, Oerline M, Braffett BH, Pop-Busui R, Wessells H, Sarma AV.
PMID: 34672384
Neurourol Urodyn. 2022 Jan;41(1):323-331. doi: 10.1002/nau.24823. Epub 2021 Oct 21.

AIMS: Urinary incontinence (UI) in women is a dynamic condition with numerous risk factors yet most studies have focused on examining its prevalence at a single time. The objective of this study was to describe the long-term time course...

Cite
Bakre S, Holt SK, Oerline M, et al. Longitudinal patterns of urinary incontinence and associated predictors in women with type 1 diabetes. Neurourol Urodyn. 2021;41(1):323-331doi: 10.1002/nau.24823.
Bakre, S., Holt, S. K., Oerline, M., Braffett, B. H., Pop-Busui, R., Wessells, H., Sarma, A. V. (2022). Longitudinal patterns of urinary incontinence and associated predictors in women with type 1 diabetes. Neurourology and urodynamics, 41(1), 323-331. https://doi.org/10.1002/nau.24823
Bakre, Shivani, et al. "Longitudinal patterns of urinary incontinence and associated predictors in women with type 1 diabetes." Neurourology and urodynamics vol. 41,1 (2022): 323-331. doi: https://doi.org/10.1002/nau.24823
Bakre S, Holt SK, Oerline M, Braffett BH, Pop-Busui R, Wessells H, Sarma AV. Longitudinal patterns of urinary incontinence and associated predictors in women with type 1 diabetes. Neurourol Urodyn. 2022 Jan;41(1):323-331. doi: 10.1002/nau.24823. Epub 2021 Oct 21. PMID: 34672384; PMCID: PMC8738144.
Copy Download .nbib Format: NLM
Type 1 diabetes and oral health: Findings from the Epidemiology of Diabetes Interventions and Complications (EDIC) study.

Journal of diabetes and its complications

Steigmann L, Miller R, Trapani VR, Giannobile WV, Braffett BH, Pop-Busui R, Lorenzi G, Herman WH, Sarma AV.
PMID: 35000860
J Diabetes Complications. 2022 Jan 03;108120. doi: 10.1016/j.jdiacomp.2021.108120. Epub 2022 Jan 03.

OBJECTIVE: To describe long-term oral health outcomes and examine associations between sociodemographic factors, clinical characteristics, and markers of diabetes control on tooth loss in participants with type 1 diabetes enrolled in the Diabetes Control and Complications Trial/Epidemiology of Diabetes...

Cite
Steigmann L, Miller R, Trapani VR, et al. Type 1 diabetes and oral health: Findings from the Epidemiology of Diabetes Interventions and Complications (EDIC) study. J Diabetes Complications. 2022;108120doi: 10.1016/j.jdiacomp.2021.108120.
Steigmann, L., Miller, R., Trapani, V. R., Giannobile, W. V., Braffett, B. H., Pop-Busui, R., Lorenzi, G., Herman, W. H., Sarma, A. V. (2022). Type 1 diabetes and oral health: Findings from the Epidemiology of Diabetes Interventions and Complications (EDIC) study. Journal of diabetes and its complications, 108120. https://doi.org/10.1016/j.jdiacomp.2021.108120
Steigmann, Larissa, et al. "Type 1 diabetes and oral health: Findings from the Epidemiology of Diabetes Interventions and Complications (EDIC) study." Journal of diabetes and its complications vol. (2022): 108120. doi: https://doi.org/10.1016/j.jdiacomp.2021.108120
Steigmann L, Miller R, Trapani VR, Giannobile WV, Braffett BH, Pop-Busui R, Lorenzi G, Herman WH, Sarma AV. Type 1 diabetes and oral health: Findings from the Epidemiology of Diabetes Interventions and Complications (EDIC) study. J Diabetes Complications. 2022 Jan 03;108120. doi: 10.1016/j.jdiacomp.2021.108120. Epub 2022 Jan 03. PMID: 35000860.
Copy Download .nbib Format: NLM
The Effect of Discontinuing Continuous Glucose Monitoring in Adults With Type 2 Diabetes Treated With Basal Insulin.

Diabetes care

Aleppo G, Beck RW, Bailey R, Ruedy KJ, Calhoun P, Peters AL, Pop-Busui R, Philis-Tsimikas A, Bao S, Umpierrez G, Davis G, Kruger D, Bhargava A, Young L, Buse JB, McGill JB, Martens T, Nguyen QT, Orozco I, Biggs W, Lucas KJ, Polonsky WH, Price D, Bergenstal RM.
PMID: 34588210
Diabetes Care. 2021 Dec;44(12):2729-2737. doi: 10.2337/dc21-1304. Epub 2021 Sep 29.

OBJECTIVE: To explore the effect of discontinuing continuous glucose monitoring (CGM) after 8 months of CGM use in adults with type 2 diabetes treated with basal without bolus insulin.RESEARCH DESIGN AND METHODS: This multicenter trial had an initial randomization...

Cite
Aleppo G, Beck RW, Bailey R, et al. The Effect of Discontinuing Continuous Glucose Monitoring in Adults With Type 2 Diabetes Treated With Basal Insulin. Diabetes Care. 2021;44(12):2729-2737doi: 10.2337/dc21-1304.
Aleppo, G., Beck, R. W., Bailey, R., Ruedy, K. J., Calhoun, P., Peters, A. L., Pop-Busui, R., Philis-Tsimikas, A., Bao, S., Umpierrez, G., Davis, G., Kruger, D., Bhargava, A., Young, L., Buse, J. B., McGill, J. B., Martens, T., Nguyen, Q. T., Orozco, I., Biggs, W., Lucas, K. J., Polonsky, W. H., Price, D., Bergenstal, R. M. (2021). The Effect of Discontinuing Continuous Glucose Monitoring in Adults With Type 2 Diabetes Treated With Basal Insulin. Diabetes care, 44(12), 2729-2737. https://doi.org/10.2337/dc21-1304
Aleppo, Grazia, et al. "The Effect of Discontinuing Continuous Glucose Monitoring in Adults With Type 2 Diabetes Treated With Basal Insulin." Diabetes care vol. 44,12 (2021): 2729-2737. doi: https://doi.org/10.2337/dc21-1304
Aleppo G, Beck RW, Bailey R, Ruedy KJ, Calhoun P, Peters AL, Pop-Busui R, Philis-Tsimikas A, Bao S, Umpierrez G, Davis G, Kruger D, Bhargava A, Young L, Buse JB, McGill JB, Martens T, Nguyen QT, Orozco I, Biggs W, Lucas KJ, Polonsky WH, Price D, Bergenstal RM. The Effect of Discontinuing Continuous Glucose Monitoring in Adults With Type 2 Diabetes Treated With Basal Insulin. Diabetes Care. 2021 Dec;44(12):2729-2737. doi: 10.2337/dc21-1304. Epub 2021 Sep 29. PMID: 34588210; PMCID: PMC8669539.
Copy Download .nbib Format: NLM
Showing 13 to 24 of 46 entries